Do Post-Market Drug Trials Need a Higher Dose of Ethics?

Say you have high blood pressure . There's a new blockbuster drug on the market, and your doctor lets you know about a new clinical trial you can join that is testing the new treatment against an old tried-and-true one. What's not to like? You're going to be taking, under the care of experts, one of two U.S. Food and Drug Administration–approved medications. [More]

Read the whole article on Scientific American

More from Scientific American